FdaApplication
NDA 020992
Identifiers
- fda_app_no: NDA020992
Properties
| Property | Value |
|---|---|
| applicant_name | ASPEN PHARMA USA INC |
| application_type | NDA |
| approval_date | 1999-03-24 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CENESTIN | ESTROGENS, CONJUGATED SYNTHETIC A | 0.625MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| CENESTIN | ESTROGENS, CONJUGATED SYNTHETIC A | 0.45MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| CENESTIN | ESTROGENS, CONJUGATED SYNTHETIC A | 0.9MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| CENESTIN | ESTROGENS, CONJUGATED SYNTHETIC A | 1.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| CENESTIN | ESTROGENS, CONJUGATED SYNTHETIC A | 0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
5 products